Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: An analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008)

Haemophilia

Volumn 16, Issue 4, 2010, Pages 625-631

  Nakar, C ^a   Cooper, D L ^b   DiMichele, D ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NOVO NORDISK INC   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Central nervous system; Haemophilia A; Haemophilia B; Inhibitors; Intracranial haemorrhage; Recombinant activated factor VII

Indexed keywords

ALLOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMOPHILIA; HEMOSTASIS; HUMAN; INJURY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD COAGULATION FACTOR INHIBITORS; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; FACTOR VIIA; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HUMANS; INFANT; INTRACRANIAL HEMORRHAGES; RECOMBINANT PROTEINS; REGISTRIES; YOUNG ADULT;

EID: 77954856457     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02208.x     Document Type: Article

References (34)

1. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003, 9:418-35.
2. DiMichele D. Inhibitors to factor VIII-epidemiology and treatment. Textbook of Hemophili 2005, 64-70. Lee CHoots KBentorp E. In, eds, Oxford, Blackwell Science
3. DiMichele D. Inhibitor development in haemophilia B: an orphan disease in need of attention. Br J Haematol 2007, 138:305-15.
4. Darby SC, Keeling DM, Spooner RJ. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost 2004, 2:1047-54.
5. Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol 2008, 140:378-84.
6. de Tezanos PM, Fernandez J, Perez Bianco PR. Update of 156 episodes of central nervous system bleeding in hemophiliacs. Haemostasis 1992, 22:259-67.
7. Nelson MD, Maeder MA, Usner D. Prevalence and incidence of intracranial haemorrhage in a population of children with haemophilia. The Hemophilia Growth and Development Study. Haemophilia 1999, 5:306-12.
8. Martinowitz U, Heim M, Tadmor R. Intracranial hemorrhage in patients with hemophilia. Neurosurgery 1986, 18:538-41.
9. Nuss R, Soucie JM, Evatt B. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol 2001, 68:37-42.
10. Traivaree C, Blanchette V, Armstrong D. Intracranial bleeding in haemophilia beyond the neonatal period - the role of CT imaging in suspected intracranial bleeding. Haemophilia 2007, 13:552-9.
11. Antunes SV, Vicari P, Cavalheiro S, Bordin JO. Intracranial haemorrhage among a population of haemophilic patients in Brazil. Haemophilia 2003, 9:573-7.
12. Stieltjes N, Calvez T, Demiguel V. Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death. Haemophilia 2005, 11:452-8.
13. Mishra P, Naithani R, Dolai T. Intracranial haemorrhage in patients with congenital haemostatic defects. Haemophilia 2008, 14:952-5.
14. Kerr CB. Intracranial haemorrhage in haemophilia. J Neurol Neurosurg Psychiatry 1964, 27:166-73.
15. Andes WA, Wulff K, Smith WB. Head trauma in hemophilia. A prospective study. Arch Intern Med 1984, 144:1981-3.
16. Eyster ME, Gill FM, Blatt PM. Central nervous system bleeding in hemophiliacs. Blood 1978, 51:1179-88.
17. Klinge J, Auberger K, Auerswald G. Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 1999, 158(Suppl. 3):S162-5.
18. Bladen M, Khair K, Liesner R, Main E. Long-term consequences of intracranial haemorrhage in children with haemophilia. Haemophilia 2009, 15:184-92.
19. Key NS, Aledort LM, Beardsley D. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 1998, 80:912-8.
20. Kempton CL, White GC. How we treat a hemophilia A patient with a factor VIII inhibitor. Blood 2009, 113:11-7.
21. Kenet G, Martinowitz U. Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors. Semin Hematol 2008, 45:S38-41.
22. Young G, Shafer FE, Rojas P, Seremetis S. Single 270 microg kg(-1)-dose rFVIIa vs. standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison. Haemophilia 2008, 14:287-94.
23. Hedner U. Recombinant factor VIIa: its background, development and clinical use. Curr Opin Hematol 2007, 14:225-9.
24. Santagostino E, Mancuso ME, Rocino A. A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors. J Thromb Haemost 2006, 4:367-71.
25. Kavakli K, Makris M, Zulfikar B. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial. Thromb Haemost 2006, 95:600-5.
26. Young JC, Cooper DL, Kessler CM. The usefulness of registry data for understanding treatment practices and clinical outcomes in hemophilia: the experience of the Hemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008). Poster PP-WE-601 presented at the International Society for Thrombosis and Hemostasis, Boston, July 2009
27. Majumdar G, Savidge GF. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors. Blood Coagul Fibrinolysis 1993, 4:1031-3.
28. Schmidt ML, Gamerman S, Smith HE, Scott JP, DiMichele DM. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors. Am J Hematol 1994, 47:36-40.
29. McPherson J, Teague L, Lloyd J. Experience with recombinant factor VIIa in Australia and New Zealand. Haemostasis 1996, 26(Suppl. 1):109-17.
30. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia 1999, 5:253-9.
31. Rice KM, Savidge GF. NovoSeven (recombinant factor VIIa) in central nervous systems bleeds. Haemostasis 1996, 26(Suppl. 1):131-4.
32. Arkin S, Cooper HA, Hutter JJ. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program. Haemostasis 1998, 28:93-8.
33. Teitel J, Berntorp E, Collins P. A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors. Haemophilia 2007, 13:256-63.
34. Perez BR, Ozelo MC, Villaca PR. Diagnosis and treatment of congenital hemophilia with inhibitors a Latin American perspective. Medicina (B Aires) 2008, 68:227-42.